N4P

N4 PHARMA PLC ORD 0.4P

TitleTime
Holding(s) in CompanyThu 21/05/20 | 16:26
Holding(s) in CompanyWed 20/05/20 | 12:29
Second Price Monitoring ExtnMon 18/05/20 | 16:41
Price Monitoring ExtensionMon 18/05/20 | 16:37
Grant of OptionsMon 18/05/20 | 16:29
Patent filing updateMon 18/05/20 | 14:25
Placing to raise £2m & appointment of Joint BrokerWed 13/05/20 | 13:58
New Nuvec® opportunity and patent filingFri 24/04/20 | 07:00
Result of AGMThu 23/04/20 | 11:01
Attendance at the Company's annual general meetingFri 17/04/20 | 07:00
Covid-19 Project UpdateThu 16/04/20 | 07:00
Second Price Monitoring ExtnWed 15/04/20 | 09:05
Price Monitoring ExtensionWed 15/04/20 | 09:00
Second Price Monitoring ExtnMon 30/03/20 | 14:05
Price Monitoring ExtensionMon 30/03/20 | 14:00
Changes to AGMWed 25/03/20 | 13:18
Covid-19 Project Update and operational updateWed 25/03/20 | 07:00
Holding(s) in CompanyMon 16/03/20 | 10:26
Posting of Annual Report and Notice of AGMWed 04/03/20 | 07:00
Final ResultsTue 25/02/20 | 07:00
Research Collaboration AgreementTue 11/02/20 | 07:00
Update on Nuvec® process improvementsWed 29/01/20 | 07:00
Interim ResultsWed 18/09/19 | 07:00
Results of University of Queensland StudyTue 20/08/19 | 07:00
Holding(s) in CompanyTue 13/08/19 | 11:16
Second Price Monitoring ExtnMon 15/07/19 | 14:05
Price Monitoring ExtensionMon 15/07/19 | 14:00
Second Price Monitoring ExtnWed 03/07/19 | 16:40
Price Monitoring ExtensionWed 03/07/19 | 16:35
Result of AGMWed 19/06/19 | 12:51
AGM StatementWed 19/06/19 | 07:00
Second Price Monitoring ExtnFri 14/06/19 | 16:41
Price Monitoring ExtensionFri 14/06/19 | 16:36
Change to Director ShareholdingTue 28/05/19 | 14:21
Posting of Annual Report and Notice of AGMWed 22/05/19 | 07:00
Board ChangesTue 21/05/19 | 07:00
Final ResultsTue 14/05/19 | 07:00
Nuvec® Research updateMon 15/04/19 | 07:00
Director/PDMR ShareholdingWed 10/04/19 | 11:52
Nuvec® Research updateTue 09/04/19 | 07:00
Holding(s) in CompanyWed 20/03/19 | 09:40
Holding(s) in CompanyWed 20/03/19 | 09:40
Total Voting RightsThu 28/02/19 | 17:00
Holding(s) in CompanyThu 14/02/19 | 14:14
Placing to raise £1.05 millionFri 08/02/19 | 12:23
Nuvec licence extensionThu 20/12/18 | 07:00
Nuvec® research updateWed 28/11/18 | 07:00
Nuvec resource changesFri 16/11/18 | 13:36
Filing of further Nuvec® patent applicationThu 15/11/18 | 07:00
Second Price Monitoring ExtnWed 14/11/18 | 11:05
Price Monitoring ExtensionWed 14/11/18 | 11:00
Second Price Monitoring ExtnWed 14/11/18 | 09:05
Price Monitoring ExtensionWed 14/11/18 | 09:00
Second Price Monitoring ExtnThu 08/11/18 | 16:40
Price Monitoring ExtensionThu 08/11/18 | 16:35
Second Price Monitoring ExtnThu 08/11/18 | 14:05
Price Monitoring ExtensionThu 08/11/18 | 14:00
Second Price Monitoring ExtnMon 05/11/18 | 11:06
Price Monitoring ExtensionMon 05/11/18 | 11:00
Price Monitoring ExtensionMon 05/11/18 | 09:00
Research collaboration updateMon 05/11/18 | 07:54
Nuvec® research updateMon 29/10/18 | 07:00
Grant of optionsWed 26/09/18 | 13:48
Price Monitoring ExtensionWed 26/09/18 | 11:00
Second Price Monitoring ExtnMon 24/09/18 | 16:41
Price Monitoring ExtensionMon 24/09/18 | 16:35
Second Price Monitoring ExtnMon 24/09/18 | 14:05
Price Monitoring ExtensionMon 24/09/18 | 14:00
Acceptance of Nuvec® on EUNCLMon 24/09/18 | 07:00
Interim ResultsThu 20/09/18 | 07:01
Strategic ReviewThu 20/09/18 | 07:00
Second Price Monitoring ExtnMon 30/07/18 | 11:05
Price Monitoring ExtensionMon 30/07/18 | 11:00
Change of AdviserMon 30/07/18 | 07:00
Holding(s) in CompanyTue 17/07/18 | 13:12
Second Price Monitoring ExtnWed 11/07/18 | 14:05
Price Monitoring ExtensionWed 11/07/18 | 14:00
Clinical trials preliminary resultsMon 09/07/18 | 07:00
Nuvec® UpdateMon 18/06/18 | 07:00
Result of AGMWed 23/05/18 | 11:31
Filing of PatentWed 09/05/18 | 07:00
Posting of Annual Report and Notice of AGMFri 27/04/18 | 11:00
Final ResultsWed 25/04/18 | 07:00
Commencement of Sildenafil Clinical TrialWed 18/04/18 | 07:00
Price Monitoring ExtensionMon 09/04/18 | 11:00
Exercise of Warrants and Total Voting RightsFri 09/03/18 | 08:43
Holding(s) in CompanyThu 08/03/18 | 10:05
Nuvec® UpdateThu 08/03/18 | 07:00
Exercise of Warrants and Total Voting RightsWed 07/03/18 | 08:33
Change of AdviserFri 02/03/18 | 12:17
Exercise of Warrants and Total Voting RightsMon 26/02/18 | 09:27
Exercise of Warrants and Total Voting RightsWed 21/02/18 | 13:36
Exercise of Warrants and Total Voting RightsMon 19/02/18 | 17:01
Exercise of Warrants and Total Voting RightsWed 14/02/18 | 17:26
Exercise of Warrants and Total Voting RightsTue 13/02/18 | 12:52
Second Price Monitoring ExtnMon 12/02/18 | 14:05
Price Monitoring ExtensionMon 12/02/18 | 14:00
Second Price Monitoring ExtnMon 12/02/18 | 11:06
Price Monitoring ExtensionMon 12/02/18 | 11:00
Holding(s) in CompanyThu 08/02/18 | 12:01
Exercise of Warrants and Total Voting RightsThu 08/02/18 | 11:46
Issue of Equity and Director/PDMR ShareholdingMon 05/02/18 | 07:00
Exercise of Warrants and Total Voting RightsFri 02/02/18 | 16:47
Award of Grant and Collaboration with MedImmune UKFri 02/02/18 | 13:04
Exercise of Warrants and Total Voting RightsTue 30/01/18 | 15:04
Exercise of Warrants and Total Voting RightsWed 24/01/18 | 16:06
Exercise of Warrants and Total Voting RightsMon 22/01/18 | 10:44
Holding(s) in CompanyMon 15/01/18 | 12:36
Exercise of Warrants and Total Voting RightsMon 08/01/18 | 14:31
Holding(s) in CompanyMon 08/01/18 | 13:26
Exercise of Warrants and Total Voting RightsThu 28/12/17 | 09:03
Filing of PatentFri 22/12/17 | 07:00
Holding(s) in CompanyMon 18/12/17 | 08:27
Exercise of Warrants and Total Voting RightsWed 13/12/17 | 16:07
Director/PDMR ShareholdingFri 10/11/17 | 16:04
Results of latest nuvec pre-clinical studyWed 08/11/17 | 07:00
Holding(s) in CompanyThu 02/11/17 | 14:31
Sildenafil PCT UpdateTue 10/10/17 | 07:00
Interim ResultsMon 25/09/17 | 07:00
Update on Sildenafil clinical plansThu 27/07/17 | 07:00
Change in Director DetailsTue 11/07/17 | 10:31
Filing of PatentTue 04/07/17 | 07:00
Update on Toxicity Testing of Nuvec® ParticlesFri 30/06/17 | 07:00